
CJC-1295 (No-DAC, also called Modified GRF 1-29) and Ipamorelin is a dual-peptide growth hormone secretagogue research formulation available in the UAE, combining 10mg of the no-DAC CJC-1295 variant with 10mg Ipamorelin in a single pre-filled injection pen.CJC-1295 (No-DAC) is a synthetic GHRH analogue with stabilising amino-acid substitutions but without the Drug Affinity Complex modification, so its half-life is closer to native GHRH (around 30 minutes) and it produces a pulsatile pattern of GH release in research models. Ipamorelin is a selective ghrelin-receptor agonist studied for pulsatile growth hormone release with minimal cortisol or prolactin elevation compared to earlier secretagogues.

